Epirubicin (EPI) and docetaxel (DOC) as primary chemotherapy (PCT) in >= 3cm breast cancerF. Conti,M. R. Valerio,P. Visca,D. Sergi, M. C. Masi, F. Spinnato,P. Foggi,A. Amodio, C. Vitucci,N. Gebbia,M. LopezANNALS OF ONCOLOGY（2005）引用 0|浏览26暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
